Renal Manifestations and Complications of Inflammatory Bowel Disease

被引:93
作者
Oikonomou, Konstantinos [1 ]
Kapsoritakis, Andreas [1 ]
Eleftheriadis, Theodoros [2 ]
Stefanidis, Ioannis [2 ]
Potamianos, Spiros [1 ]
机构
[1] Univ Thessaly, Sch Med, Dept Gastroenterol, Larisa, Greece
[2] Univ Thessaly, Sch Med, Dept Nephrol, Larisa, Greece
关键词
inflammatory bowel disease; enteric hyperoxaluria; glomerulonephritis; tubulointerstitial nephritis; nephrotoxic drugs; ANTI-TNF-ALPHA; SERUM CYSTATIN-C; ACETYL-BETA-GLUCOSAMINIDASE; CHRONIC ULCERATIVE-COLITIS; CROHNS-DISEASE; INTERSTITIAL NEPHRITIS; IGA NEPHROPATHY; RHEUMATOID-ARTHRITIS; SYSTEMIC AMYLOIDOSIS; EXTRAINTESTINAL MANIFESTATIONS;
D O I
10.1002/ibd.21468
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Renal manifestations and complications are not rare in patients with inflammatory bowel disease (IBD) and may present as nephrolithiasis, amyloidosis, tubulointerstitial nephritis, and glomerulonephritis. Symptoms of renal impairment are not always specific and since the underlying bowel disease is preponderant, renal function deterioration may be underestimated. Additionally, medical treatment of patients with IBD such as aminosalicylates, cyclosporine, and tumor necrosis factor-alpha inhibitors can cause renal complications, although direct correlation to bowel disease is not always clear. The well-documented renal manifestations and complications of IBD, as well as the possible renal side effects of new drugs, emphasize the need for periodic evaluation of renal function. New markers of renal function may facilitate early diagnosis and unravel the complex mechanisms responsible for kidney damage. The purpose of this review is to summarize the renal manifestations and complications as well as the markers of renal function utilized in IBD, attempting to shed more light on the pathophysiology of renal damage in IBD.
引用
收藏
页码:1034 / 1045
页数:12
相关论文
共 135 条
[1]
CHOLELITHIASIS AND UROLITHIASIS IN CROHNS-DISEASE [J].
ANDERSSON, H ;
BOSAEUS, I ;
FASTH, S ;
HELLBERG, R ;
HULTEN, L .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1987, 22 (02) :253-256
[2]
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab [J].
Anelli, MG ;
Torres, DD ;
Manno, C ;
Scioscia, C ;
Iannone, F ;
Covelli, M ;
Schena, FP ;
Lapadula, G .
ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2519-2520
[3]
ARCHIMANDRITIS AJ, 1993, BMJ-BRIT MED J, V28, P540
[4]
Ashman N, 2003, CLIN NEPHROL, V60, P146
[5]
BARBOUR VM, 1990, BMJ-BRIT MED J, V6, P818
[6]
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease - A long-term follow-up [J].
Baumgart, Daniel C. ;
Pintoffl, Jan P. ;
Sturm, Andreas ;
Wiedenmann, Bertram ;
Dignass, Axel U. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (05) :1048-1056
[7]
Urinary N-acetyl-β-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis [J].
Bazzi, C ;
Petrini, C ;
Rizza, V ;
Arrigo, G ;
Napodano, P ;
Paparella, M ;
D'Amico, G .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (11) :1890-1896
[8]
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy [J].
Bennett, WM ;
DeMattos, A ;
Meyer, MM ;
Andoh, T ;
Barry, JM .
KIDNEY INTERNATIONAL, 1996, 50 (04) :1089-1100
[9]
Mechanisms of acute and chronic nephrotoxicity from immunosuppressive drugs [J].
Bennett, WM .
RENAL FAILURE, 1996, 18 (03) :453-460
[10]
Bennett WM, 1996, NEPHROL DIAL TRANSPL, V11, P2108, DOI 10.1093/oxfordjournals.ndt.a027115